|
PSMA4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21369999997556E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.409800E-04 |
| Normal-vs-Stage2 |
4.660900E-03 |
| Normal-vs-Stage3 |
8.0057999999994E-05 |
| Normal-vs-Stage4 |
3.75569997324021E-09 |
| Stage1-vs-Stage2 |
2.866000E-01 |
| Stage1-vs-Stage3 |
2.614200E-01 |
| Stage1-vs-Stage4 |
3.86060000000521E-05 |
| Stage2-vs-Stage3 |
6.726800E-01 |
| Stage2-vs-Stage4 |
3.979700E-02 |
| Stage3-vs-Stage4 |
1.160850E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66250000047208E-07 |
| Normal-vs-AfricanAmerican |
3.676400E-03 |
| Normal-vs-Asian |
2.712200E-01 |
| Caucasian-vs-AfricanAmerican |
8.562600E-01 |
| Caucasian-vs-Asian |
5.538000E-01 |
| AfricanAmerican-vs-Asian |
6.142800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54513999999217E-05 |
| Normal-vs-Female |
1.09020000027549E-07 |
| Male-vs-Female |
1.761180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.927500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.08489999999895E-05 |
| Normal-vs-Age(61-80Yrs) |
4.5002000004235E-07 |
| Normal-vs-Age(81-100Yrs) |
5.364300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.680800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.148600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.354400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.780800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.209200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.568400E-02 |
| Normal-vs-Grade 2 |
1.66211999999E-05 |
| Normal-vs-Grade 3 |
1.431630E-04 |
| Normal-vs-Grade 4 |
1.06210000017093E-07 |
| Grade 1-vs-Grade 2 |
6.415800E-01 |
| Grade 1-vs-Grade 3 |
8.034000E-01 |
| Grade 1-vs-Grade 4 |
2.157700E-02 |
| Grade 2-vs-Grade 3 |
5.257400E-01 |
| Grade 2-vs-Grade 4 |
4.118300E-03 |
| Grade 3-vs-Grade 4 |
1.437900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.05529999999232E-05 |
| Normal-vs-ccB subtype |
1.264020E-03 |
| ccA subtype-vs-ccB subtype |
3.293600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.35880000052514E-07 |
| Normal-vs-N1 |
2.356100E-03 |
| N0-vs-N1 |
9.470300E-02 |
|
|
